Among Tau-related biomarkers, t-tau has also been found to be elevated in a variety of neurological diseases, so it is considered to be a related biomarker of neuronal damage and has low specificity for AD (Schöll et al., 2019). This evidence concerns the gene MAPT and nervous system disorder.